These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1260681)

  • 1. Ultrasonic enhancement of nitrogen mustard cytotoxicity in mouse leukemia.
    Kremkau FW; Kaufmann JS; Walker MM; Burch PG; Spurr CL
    Cancer; 1976 Apr; 37(4):1643-7. PubMed ID: 1260681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells.
    Naujokaitis SA; Fisher JM; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):305-18. PubMed ID: 7302378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of priming dose schedules in cytoxan treatment of mouse leukemia L1210.
    Straus MJ; Goldin A
    Proc Soc Exp Biol Med; 1974 Mar; 145(3):1132-8. PubMed ID: 4818588
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.
    Ewig RA; Kohn KW
    Cancer Res; 1977 Jul; 37(7 Pt 1):2114-22. PubMed ID: 558823
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapeutic, carcinogenic, and cell-regulatory effects of triazenes.
    Schmid FA; Hutchison DJ
    Cancer Res; 1974 Jul; 34(7):1671-5. PubMed ID: 4833916
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of reserpine (NSC-59272)-induced hypothermia on lifespan in mouse L1210 leukemia.
    Fondy TP; Karker KL; Calcagnino C; Emlich CA
    Cancer Chemother Rep; 1974; 58(3):317-24. PubMed ID: 4841715
    [No Abstract]   [Full Text] [Related]  

  • 7. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of transplantability and tumor growth following treatment of L1210 leukemia and TA3Ha cells with macromomycin (NSC-170105).
    Lippman MM; Abbott BJ
    Cancer Chemother Rep; 1973; 57(4):501-3. PubMed ID: 4762442
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral and parenteral activity of 2,2'-anhydro-1- -D-arabinofuranosyl-5-fluorocytosine against both intraperitoneally and intracerebrally inoculated mouse leukemia.
    Fox JJ; Falco EA; Wempen I; Pomeroy D; Dowling MD; Burchenal JH
    Cancer Res; 1972 Oct; 32(10):2269-72. PubMed ID: 4673145
    [No Abstract]   [Full Text] [Related]  

  • 10. Attempted use of zinc in vivo to protect against nitrogen mustard toxicity in tumor-free and in L1210 leukemia-bearing female B6D2F1 mice.
    Shackelford ME; Tobey RA
    J Appl Toxicol; 1992 Aug; 12(4):295-300. PubMed ID: 1430782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal potentiation of the antitumor activity of alkylating drugs.
    Rutman RJ; Ritter CA; Avadhani NG; Hansel J
    Cancer Treat Rep; 1976 May; 60(5):617-8. PubMed ID: 991151
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
    WU FY; Le Pecq JB
    Mol Pharmacol; 1983 Jan; 23(1):182-9. PubMed ID: 6346048
    [No Abstract]   [Full Text] [Related]  

  • 13. Thiamine protection of murine L1210 leukemia cells against mechlorethamine cytotoxicity and its relation to the choline uptake system.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):317-27. PubMed ID: 7244366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thiourea on survival and DNA cross-link formation in cells treated with platinum(II) complexes, L-phenylalanine mustard, and bis(2-chloroethyl)methylamine.
    Zwelling LA; Filipski J; Kohn KW
    Cancer Res; 1979 Dec; 39(12):4989-95. PubMed ID: 498125
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity of cyclodepsipeptides on murine lymphocytes and on L 1210 leukemia cells.
    Morel E; Pais M; Turpin M; Guyot M
    Biomed Pharmacother; 1983; 37(4):184-5. PubMed ID: 6661504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of murine L1210 leukemia and bone marrow progenitor cells against mechlorethamine and inhibition of choline uptake as a structure-activity relationship of 2-dimethylaminoethanol and its analogues.
    Naujokaitis SA; Fisher JM; Rabinovitz M
    J Pharm Sci; 1984 Jan; 73(1):34-9. PubMed ID: 6694079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
    Surya YA; Rosenfeld JM; Hillcoat BL
    Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.
    Kline I; Gang M; Woodman RJ; Cysyk RL; Venditti JM
    Cancer Chemother Rep; 1973; 57(3):299-304. PubMed ID: 4751256
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
    Cass CE; Au-Yeung TH
    Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.